Jessica M Page1, Amanda A Allshouse, Irina Cassimatis, Marcela C Smid, Erol Arslan, Vanessa Thorsten, Corette Parker, Michael W Varner, Donald J Dudley, George R Saade, Robert L Goldenberg, Barbara J Stoll, Carol J Hogue, Radek Bukowski, Deborah Conway, Halit Pinar, Uma M Reddy, Robert M Silver. 1. University of Utah Health, Salt Lake City, Utah; Intermountain Health Care, Murray, Utah; Northwestern University, Feinberg School of Medicine, Chicago, Illinois; RTI International, Research Triangle Park, North Carolina; the University of Health Sciences, Van Training and Research Hospital, Van, Turkey; University of Virginia Healthcare, Charlottesville, Virginia; the University of Texas Medical Branch at Galveston, Galveston, Texas; Columbia University, New York, New York; the University of Texas Health Science Center at Houston, Houston, Texas; the Rollins School of Public Health, Emory University, Atlanta, Georgia; the University of Texas at Austin, Austin, Texas; the University of Texas Health Science Center at San Antonio, San Antonio, Texas; Brown University, Providence, Rhode Island; and Yale School of Medicine, New Haven, Connecticut.
Abstract
OBJECTIVE: To characterize stillbirths associated with pregestational diabetes and gestational diabetes mellitus (GDM) in a large, prospective, U.S. case-control study. METHODS: A secondary analysis of stillbirths among patients enrolled in a prospective; multisite; geographically, racially, and ethnically diverse case-control study in the United States was performed. Singleton gestations with complete information regarding diabetes status and with a complete postmortem evaluation were included. A standard evaluation protocol for stillbirth cases included postmortem evaluation, placental pathology, clinical testing as performed at the discretion of the health care professional, and a recommended panel of tests. A potential cause of death was assigned to stillbirth cases using a standardized classification tool. Demographic and delivery characteristics among women with pregestational diabetes and GDM were compared with characteristics of women with no diabetes in pairwise comparisons using χ or two-sample t tests as appropriate. Sensitivity analysis was performed excluding pregnancies with genetic conditions or major fetal malformations. RESULTS: Of 455 stillbirth cases included in the primary analysis, women with stillbirth and diabetes were more likely to be older than 35 years and have a higher body mass index. They were also more likely to have a gestational hypertensive disorder than women without diabetes (28% vs 9.1%; P<.001). Women with pregestational diabetes had more large-for-gestational-age (LGA) neonates (26% vs 3.4%; P<.001). Stillbirths occurred more often at term in women with pregestational diabetes (36%) and those with GDM (52%). Maternal medical complications, including pregestational diabetes and others, were more often identified as a probable or possible cause of death among stillbirths with maternal diabetes (43% vs 4%, P<.001) as compared with stillbirths without diabetes. CONCLUSION: Compared with stillbirths in women with no diabetes, stillbirths among women with pregestational diabetes and GDM occur later in pregnancy and are associated with hypertensive disorders of pregnancy, maternal medical complications, and LGA.
OBJECTIVE: To characterize stillbirths associated with pregestational diabetes and gestational diabetes mellitus (GDM) in a large, prospective, U.S. case-control study. METHODS: A secondary analysis of stillbirths among patients enrolled in a prospective; multisite; geographically, racially, and ethnically diverse case-control study in the United States was performed. Singleton gestations with complete information regarding diabetes status and with a complete postmortem evaluation were included. A standard evaluation protocol for stillbirth cases included postmortem evaluation, placental pathology, clinical testing as performed at the discretion of the health care professional, and a recommended panel of tests. A potential cause of death was assigned to stillbirth cases using a standardized classification tool. Demographic and delivery characteristics among women with pregestational diabetes and GDM were compared with characteristics of women with no diabetes in pairwise comparisons using χ or two-sample t tests as appropriate. Sensitivity analysis was performed excluding pregnancies with genetic conditions or major fetal malformations. RESULTS: Of 455 stillbirth cases included in the primary analysis, women with stillbirth and diabetes were more likely to be older than 35 years and have a higher body mass index. They were also more likely to have a gestational hypertensive disorder than women without diabetes (28% vs 9.1%; P<.001). Women with pregestational diabetes had more large-for-gestational-age (LGA) neonates (26% vs 3.4%; P<.001). Stillbirths occurred more often at term in women with pregestational diabetes (36%) and those with GDM (52%). Maternal medical complications, including pregestational diabetes and others, were more often identified as a probable or possible cause of death among stillbirths with maternal diabetes (43% vs 4%, P<.001) as compared with stillbirths without diabetes. CONCLUSION: Compared with stillbirths in women with no diabetes, stillbirths among women with pregestational diabetes and GDM occur later in pregnancy and are associated with hypertensive disorders of pregnancy, maternal medical complications, and LGA.
Authors: I F Casson; C A Clarke; C V Howard; O McKendrick; S Pennycook; P O Pharoah; M J Platt; M Stanisstreet; D van Velszen; S Walkinshaw Journal: BMJ Date: 1997-08-02
Authors: Halit Pinar; Matthew A Koch; Hal Hawkins; Josefine Heim-Hall; Carlos R Abramowsky; Vanessa R Thorsten; Marshall W Carpenter; Hong Holly Zhou; Uma M Reddy Journal: Am J Perinatol Date: 2011-08-03 Impact factor: 1.862
Authors: Halit Pinar; Matthew A Koch; Hal Hawkins; Josefine Heim-Hall; Bahig Shehata; Vanessa R Thorsten; Marshall Carpenter; Amy Lowichik; Uma M Reddy Journal: Am J Perinatol Date: 2011-06-29 Impact factor: 1.862
Authors: I dos Santos Silva; C Higgins; A J Swerdlow; S P Laing; S D Slater; D W M Pearson; A D Morris Journal: Diabet Med Date: 2005-04 Impact factor: 4.359
Authors: Melissa G Rosenstein; Yvonne W Cheng; Jonathan M Snowden; James M Nicholson; Amy E Doss; Aaron B Caughey Journal: Am J Obstet Gynecol Date: 2012-04 Impact factor: 8.661